Response to Determination of Oral Doxycycline Efficacy for Clearance of Borrelia burgdorferi Infection.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Wormser GP;Wormser GP
  • Source:
    The Journal of infectious diseases [J Infect Dis] 2022 Mar 15; Vol. 225 (6), pp. 1112-1113.
  • Publication Type:
    Editorial; Comment
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
    • Publication Information:
      Publication: Jan. 2011- : Oxford : Oxford University Press
      Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press
    • Subject Terms:
      Borrelia burgdorferi* ; Lyme Disease*/drug therapy; Doxycycline/therapeutic use ; Humans
    • Comments:
      Comment on: J Infect Dis. 2022 Mar 15;225(6):1113. (PMID: 34623448)
    • Accession Number:
      N12000U13O (Doxycycline)
    • Publication Date:
      Date Created: 20211008 Date Completed: 20220509 Latest Revision: 20220509
    • Publication Date:
      20240829
    • Accession Number:
      10.1093/infdis/jiab520
    • Accession Number:
      34623446